Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047707A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
11/02/2000EP1047453A1 Method for determining gene essentiality in a pathogen
11/02/2000EP1047451A1 Use of heat shock proteins to deliver moieties into cells
11/02/2000EP1047448A1 Dna vaccines against tick-borne flaviviruses
11/02/2000EP1047446A1 Vaccine composition for herpes simplex virus and methods of using
11/02/2000EP1047442A1 Bone morphogenetic proteins and their use in bone growth
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0822991A4 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus
11/02/2000EP0812207B1 Morphogen-induced dentine regeneration
11/02/2000EP0784626A4 Novel protein marker and dna encoding same
11/02/2000DE19919205A1 Diagnostischer Marker für das Humanherz Diagnostic marker for the human heart
11/02/2000DE19549523C2 New proteins from porcine reproductive and respiratory syndrome virus
11/02/2000CA2650236A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371253A1 Genome sequence and polypepides of pyrococcus abissy, fragment and uses thereof
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371220A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
11/02/2000CA2371216A1 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2371022A1 Genetically engineered oral commensal organisms as vaccines
11/02/2000CA2371006A1 Protein-protein interactions
11/02/2000CA2370541A1 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
11/02/2000CA2370482A1 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma
11/02/2000CA2370404A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000CA2370391A1 Method for down-regulating il5 activity
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370302A1 Insulin crystals for pulmonary administration
11/02/2000CA2370298A1 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000CA2370292A1 Transcriptional activation inhibitory protein
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370284A1 Membrane disruptive peptides covalently oligomerized
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369362A1 Maize npr1 polynucleotides and methods of use
11/02/2000CA2369324A1 G-protein coupled receptor and method of using same
11/02/2000CA2369058A1 Synthetic gene for expressing active retroviral protein in eukaryotes
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367830A1 Method of inhibiting leukocyte adhesion to fibrinogen
11/02/2000CA2367750A1 Tribonectins
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
11/01/2000CN1272118A Collagen type I and type III adhesive compositions
11/01/2000CN1272115A Human VAMP-2 like gene (CBCBMH06)
11/01/2000CN1272062A Immunogenic conjugates comprising group meningococcal porin and an i (H. influenzae) polysaccharide
11/01/2000CN1271736A Process for preparing mouse nerve growth factor
11/01/2000CN1271735A Anti-neuroexcitation peptide of scorpion
11/01/2000CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives
10/2000
10/31/2000US6140552 Transgenic or chimeric cattle whose mammary gland cells contain a nucleic acid construct of dna encoding a signal sequence, a polypeptide of interest and a regulatory sequence; for production of heterologous proteins in milk
10/31/2000US6140509 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/31/2000US6140490 Pure and non-naturally occurring rna specific rna sequence and capable of binding to c1q; identified through selex method; for drugs which suppress and activate the complement system and for diagnostic agents
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140486 Isolated nucleic acid having a defined nucleotide sequence from vibrio marinus; for production docosahexanoic acid in transgenic plants; nutrients; dietetics
10/31/2000US6140485 Nucleic acid encoding human neuronal calcium channel subunits
10/31/2000US6140484 Bax ω protein and methods
10/31/2000US6140483 Human polyhomeotic 2 (hph2) acts as a tumor suppressor
10/31/2000US6140476 Rep-max protein having anti-oncogenic activity and uses thereof
10/31/2000US6140475 Controlled dissolution crosslinked protein crystals
10/31/2000US6140473 Antibodies specific for MTS2 Polypeptide
10/31/2000US6140472 Use of chimeric vaccinia virus complement control proteins to inhibit complement
10/31/2000US6140469 Protein isolate having an increased level of isoflavone compounds and process for producing the same
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140465 Bau, a BIN1 interacting protein, and uses therefor
10/31/2000US6140464 Nonapeptides that bind a HLA-A2.1 molecule
10/31/2000US6140306 Concurrently administering to a patient a (bpi)bactericidal/permeability-increasing protein and a tetracyline antibiotic in the treatment of a patient infected with escherichia gram-negative bacterial species
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140132 Amino acid sequence of modified aequorea green fluorescent protein having specific substitutions; for determining ph in cellular organelles
10/31/2000US6140120 Regulated transcription of targeted genes and other biological events
10/31/2000US6140117 Ninjurin
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140113 Nucleotide sequences which codes an immunoglobulin fusion protein; for the detection and treatment of allergies, autoimmune diseases, tumors, infections, and transplant ejection; antitumor agents
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140103 Regulated protein expression in stably transfected mammalian cells
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/31/2000US6140085 Genetic control of flowering
10/31/2000US6140084 Nucleotide sequences coding a polypeptide useful for the detection, diagnosis, prevention, and treatment of thyroid, pituitary, colon, bone and endocrine cancers
10/31/2000US6140083 Leptospiral outer membrane protein, LipL46
10/31/2000US6140082 Nucleotide sequences comprising bordetella regulatory sequences; for the expression of heterologous proteins
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140079 Nucleotide sequence coding staphylococcal protein; for the prevention of bacterial infection and development of bactericides
10/31/2000US6140078 Derivable from a lactic acid bacterium in isolation from the coding sequence normally controlled by said promoter in a wild-type lactic acid bacterium
10/31/2000US6140076 Ig superfamily `dlair` receptors expressed in monocytes
10/31/2000US6140075 Method for producing antibodies and protein toxins in plant cells
10/31/2000US6140073 Useful in the promotion of tissue repair
10/31/2000US6140072 Functional recombinantly prepared synthetic protein polymer
10/31/2000US6140071 Proteins with mutations to decrease N-terminal methylation
10/31/2000US6140068 Compositions of the present invention are based on the discovery that peptides containing the amino acid sequence phsrn promote wound healing
10/31/2000US6140066 Methods of cancer diagnosis using a chimeric toxin
10/31/2000US6140064 Identifying ligands, and inhibitors (e.g., antagonists) or promoters (e.g., agonists) of receptor function, including methods in which host cells comprising a nucleic acid encoding a cxcr3 or variant thereof are used in an assay to identify
10/31/2000US6140061 Response regulator
10/31/2000US6140060 Cloned lysophosphatidic acid receptors
10/31/2000US6140059 Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
10/31/2000US6140058 Activation of p53 protein
10/31/2000US6140052 Diagnosing and treating cancers by determining the presence or absence in a cell of wild-type adenomatous polyposis coli (apc) or a wild-type downstream protein in the apc transcription regulatory pathway
10/31/2000US6140050 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
10/31/2000US6140046 Using oligonucleotide probes
10/31/2000US6140043 Pharmaceutical composition comprising a protein, peptide or a functionally equivalent molecule
10/31/2000US6140042 TAB1 protein and DNA coding therefore
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139843 Administering a polypeptide conjugate compositions to enhance immunogenicity, for treatment and prevention of viral infections
1 ... 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 ... 2916